The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
ASAP CRN Discovery Fellowship 2025, 2026Exploring How Mutations in the LRRK2 Gene Change mRNA and Protein Selection and How This Can Be Used for Diagnosis and Treatment of Parkinson’s Disease
Study Rationale:
Mutations in the LRRK2 gene are the most common inherited cause of Parkinson’s disease. These changes affect how cells read and process genetic messages, producing different versions...
-
ASAP CRN 2025 RFA Scientific Track, 2026RNA Mechanisms of Resilience and Vulnerability in Aging and Parkinson’s Disease
Study Rationale:
Parkinson’s disease (PD) is the fastest-growing neurodegenerative disorder, yet we still don’t fully understand why brain cells become vulnerable and die. Recent work suggests...
-
ASAP CRN 2025 RFA Scientific Track, 2026Environmental & Genetic Determinants of Parkinson’s Disease Progression
Study Rationale:
Several genetic and environmental factors determine the risk of developing Parkinson’s disease (PD) and how fast the disease progresses. We have identified 2...
-
ASAP CRN 2025 RFA Scientific Track, 2026Defining Separate Rewarding and Aversive Dopaminergic Circuits and Their Role in Parkinson's Disease Associated Pain
Study Rationale:
Parkinson’s disease (PD) has traditionally been defined by people having trouble moving — walking, standing up, etc., but non-movement related symptoms...
-
ASAP CRN Discovery Fellowship 2025, 2026Identifying Common, Non-Coding Genetic Drivers of Neuroinflammation in Parkinson’s Disease
Study Rationale:
Accumulating evidence supports a link between inflammation and Parkinson’s disease (PD). However, researchers do not fully understand which parts of the immune system are important or...
-
Research Grant, 2026A Patient Reported Outcome Assessment for Patients with Early Parkinson’s Disease
Study Rationale:
There are no validated tools to assess functional changes in people living with PD (PwP) at the earliest clinical stages. Available tools lack sufficient sensitivity...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.